Michael B. Chancellor 13D and 13G filings for Lipella Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-17 5:00 pm Unchanged | 2024-10-15 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,642 16.000% | 0 (Unchanged) | Filing |
| 2024-08-19 4:05 pm Purchase | 2024-08-16 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,642 18.800% | 16,667 (+8.64%) | Filing |
| 2024-03-15 12:15 pm Purchase | 2024-03-13 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 192,975 20.000% | 18,113 (+10.36%) | Filing |
| 2024-03-06 5:03 pm Purchase | 2024-03-04 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 174,862 18.900% | 10,833 (+6.60%) | Filing |
| 2023-06-21 5:07 pm Purchase | 2023-06-16 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 164,029 20.800% | 164,029 (New Position) | Filing |